PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-235

  1. 14,651 Posts.
    lightbulb Created with Sketch. 1583
    Thanks for your input
    Here’s the thing
    If the readout re DMD trial is Stella good
    FDA could give Per the green light as soon as end 24 ..
    PER has stated that they will take the Tox first to the FDA
    Then take the readout to the FDA soon after..
    Because of the urgency for DMD sufferers there is no time to waste
    FDA has set a precedence ..
    We wait

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $5.924K 592.3K

Buyers (Bids)

No. Vol. Price($)
1 4056872 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3764467 6
View Market Depth
Last trade - 15.43pm 16/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.